The most influential oncology meeting in Europe, in partnership with the EACR.
IMPORTANT! Beware of fraudulent websites offering registration or accommodation!
Find out who the candidates running for the ESMO Presidency and the three new Director positions in the Executive Board are. Elected members will join the Executive Board as of 1 January 2020 and will guide ESMO in the years to come.
Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates.
The ESMO-MCBS scale is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
ESMO Elections 2019: how to vote
From 18 to 30 June ESMO members will have the opportunity to vote via the online electronic voting system within the myESMO area of the ESMO website. Watch the video to learn how to vote.
25 Jun 2019
More research is also needed to identify optimal biomarkers
24 Jun 2019
Extended deadline: Friday 28.6.2019
24 Jun 2019
NeoCombi and OpACIN-neo point to a critical assessment of patterns of relapse to two neoadjuvant treatment approaches
21 Jun 2019
An update on the registration-enabling ARROW study
19 Jun 2019
Efficacy was investigated in patients who had disease progression on or after two or more prior lines of therapy and enrolled in the KEYNOTE-158 Cohort...
19 Jun 2019
Latest data from KEYNOTE-001 study provide the longest efficacy/safety follow-up in this setting
Barcelona, Spain
03 Jul
- 06 Jul
2019
Zurich, Switzerland
03 Jul
- 04 Jul
2019
Valencia, Spain
18 Jul
- 23 Jul
2019
Oxford, United Kingdom
23 Aug
- 25 Aug
2019
Barcelona, Spain
30 Aug
- 31 Aug
2019
Naples, Italy
01 Sep
- 06 Sep
2019
